|Podcasts|February 22, 2018
Episode 3: Pharma's Reputation
Author(s)Michelle Maskaly, Christen Harm
In this episode, Christen and Michelle talk to Devyn Smith, chief strategy officer and head of operations for Sigilon Therapeutics, on the topic of pharma's reputation, both in the US and Europe.
Advertisement
In this episode, Christen and Michelle talk to Devyn Smith, chief strategy officer and head of operations for Sigilon Therapeutics, on the topic of pharma's reputation, both in the US and Europe.
You can listen and/or download the episode on SoundCloud or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
AI has Redefined Healthcare Communication — and There’s No Opting Out
2
Novo Nordisk Signs Deal with Hims & Hers
3
Mergers and Acquisitions Roundup: GSK and Alfasigma Enter Licensing Agreement for Linerixibat, Servier Enters $2.5 Billion Definitive Agreement to Acquire Day One Pharmaceuticals
4
How FDA's Removal of the Two-Trial Requirement Affects Development Programs
5